Lithium and psychosis revisited

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 2, 1998, Pages 249-263

  Kingsbury, Steven J ^a,b   Garver, David L ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Challenge tests; Heterogeneity; Lithium; Lithium transport; Physostigmine; Psychosis

Indexed keywords

ACETYLCHOLINE; DOPAMINE; LITHIUM; SEROTONIN;

DISEASE CLASSIFICATION; DISEASE COURSE; DRUG RESPONSE; HUMAN; HYPOTHESIS; PATHOGENESIS; PHENOMENOLOGY; PSYCHOPHARMACOLOGY; PSYCHOSIS; REVIEW; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; HUMANS; LITHIUM; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0032006513     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(98)00002-5     Document Type: Review

References (42)

1. ALEXANDER, P. E., VAN KAMMEN, D. P. and BUNNEY, W. E. (1979) Antipsychotic effects of lithium in schizophrenia. Am. J. Psychiat.. 136: 283-287.
2. AKISKAL, H. S. and MCKINNEY, W. T. (1975) Overview of recent research in depression: Integration of ten conceptual models into a comprehensive clinical frame. Arch. Gen. Psychiat. 32: 285-305.
3. AMERICAN PSYCHIATRIC ASSOCIATION. (1968) Diagnostic and Statistical Manual of Mental Disorders, 2nd Ed. Washington, D.C.: American Psychiatric Press.
4. AMERICAN PSYCHIATRIC ASSOCIATION. (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed. Washington, D.C.: American Psychiatric Press.
5. AMERICAN PSYCHIATRIC ASSOCIATION. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, D.C.: American Psychiatric Press.
6. ANDREASEN, N. C., ARNDT, S., O'LEARY, D., FLAUM, M. and NOPOULOS, P. (1995) Cognitive presentation and cognitive dysfunction in schizophrenia. In: Critical Issues in the Treatment of Schizophrenia N. BRUNELLO, G. RACAGNI, S. Z. LANGER and J. MENDLEWICZ (Eds.), pp. 1-8 Karger, New York.
7. ANDREASEN, N. C. and CARPENTER, W. T. (1993) Diagnosis and classification of schizophrenia. Schizophrenia Bull. 19: 199-214.
8. CARLSSON, A. (1995) The dopamine hypothesis revisited. In: Schizophrenia S. R. HIRSCH and D. R. WEINBERGER (Eds.), Schizophrenia, pp. 379-400 Blackwell, Cambridge, MA.
9. CARPENTER, W. T., STRAUSS, J. S. and BARTKO, J. S. (1973) Flexible system for the diagnosis of schizophrenia: Report from the WHO International Pilot Study of Schizophrenia. Science. 182: 1275-1278.
10. DORUS, E., PANDEY, G. N., and DAVIS, J. M. (1975) Genetic determinant of lithium ion distribution. Arch. Gen. Psychiat. 32: 1097-1102.
11. EDELSTEIN, P., SCHULTZ, J. B., HIRSCHOWITZ, J., KANTER, D. R. and GARVER, D. L. (1981) Physostigmine and lithium response in the schizophrenias. Am. J. Psychiat. 138: 1078-1081.
12. FLAUM, M and SCHULTZ, S. K. (1996) Clinical case conference: When does amphetamine-induced psychosis become schizophrenia? Am. J. Psychiat. 153: 812-815.
13. FRAZER, A., GOTLIEB, J., and MENDELS, J. (1977) Lithium ratio and clinical response in manic-depressive illness. Lancet. 1: 41-42.
14. GARVER, D. L., HIRSCHOWITZ, J., FLEISHMANN, R. and DJURIC, P. E. (1984) Lithium response and psychoses: A double-blind, placebo-controlled study. Psychiat. Res. 12: 57-68.
15. GARVER, D. L., HITZEMANN, R. and HIRSCHOWITZ, J. (1984) Lithium ratio in vitro. Arch. Gen. Psychiat. 41: 497-505.
16. GARVER, D. L., KELLY, K., FRIED, K. A., MAGNUSSON, M. and HIRSCHOWITZ, J. (1988) Drug response patterns as a basis of nosology for the mood-incongruent psychoses (the schizophrenias). Psychological Med. 18: 873-885.
17. GARVER, D. L., STWINBERG, J. L., MCDERMOTT, B. E., YAO, J. K., RAMBERG, J. E., LEWIS, S. and KINGSBURY, S. J. (1997) Etiologic heterogeneity of the psychoses: Is there a dopamine psychosis? Neuropsychopharmacology. 16(3): 191-201.
18. GOFF. D. C., AMICO, E., DREYFUSS, D. and CIRAULO, D. (1994) A placebo-controlled trial of trihexyphenidyl in unmedicated patients with schizophrenia. Am. J. Psychiat. 131: 429-431.
19. HIRSCHOWITZ, J., CASPER, R., GARVER, D. L and CHANG, S. (1980) Lithium response in good prognosis schizophrenia. Am. J. Psychiat. 137: 916-920.
20. HIRSCHOWITZ, J., ZEMLAN, F. P. and GARVER, D. L. (1982) Growth hormone levels and lithium ratios as predictors of success of lithium treatment in schizophrenia. Am. J. Psychiat. 139: 646-649.
21. HITZEMANN, R. J. and GARVER, D. L. (1982) Membrane abnormalities in schizophrenia. Psychopharmacology Bull. 18: 190-192.
22. HITZEMANN, R., MARK, C., HIRSCHOWITZ, J. and GARVER, D. L. (1985) Characteristics of phospholipid methylation in human erythrocyte ghosts: Relationship(s) to the psychoses and affective disorders. Biol. Psychiat. 20: 397-407.
23. HITZEMANN, R., MARK, C., HIRSCHOWITZ, J. and GARVER, D. L. (1989) RBC lithium transport in the psychoses. Biol. Psychiat. 25: 296-304.
24. JANICAK, P. G., DAVIS, J. M., PRESKORN, S. H. and AYD, F. J. (1993) Principles and Practice of Psychopharmacology. Williams & Wilkins, Baltimore, MD.
25. JEFFERSON, J. W., GREIST, J. H., ACKERMAN, D. L. and CARROLL, J. A. (1987) Lithium Encyclopedia for Clinical Practice, 2nd Ed. American Psychiatric Press, Washington, D.C.
26. KANE, J. M. (1994) Efficacy, mechanisms, and side effects of typical and atypical neuroleptics. In: Schizophrenia: From Mind to Molecule N. C. ANDREASEN (Ed.), pp. 173-187 American Psychiatric Press, Washington, D.C.
27. KAPLAN, M. J., LAZOFF, M., KELLY, K., LUKIN, R. and GARVER, D. L. (1990) Enlargement of cerebral third ventricle in psychotic patients with delayed response to neuroleptics. Biol. Psychiat. 27: 205-214.
28. KNABLE, M. B., KLEIMMAN, J. E. and WEINBERGER, D. R. (1995) Neurobiology of schizophrenia. In: The American Psychiatric Association Textbook of Psychopharmacology A. F. SCHATZBERG and C. B. NEMEROFF (Eds.), pp. 479-499 American Psychiatric Press, Washington, D.C.
29. LENOX, R. H. and MANJI, H. K. (1995) Lithium. In: The American Psychiatric Association Textbook of Psychopharmacology A. F. SCHATZBERG and C. B. NEMEROFF (Eds.), pp. 303-349 American Psychiatric Press, Washington, D.C.
30. MANJI, H. K., POTTER, W. Z. and LENOX, R. H. (1995) Signal transduction pathways: Molecular targets for lithium's actions. Arch. Gen. Psychiatry. 52: 531-543.
31. MCCABE, M. S., FOWLER, R. C., CADORET, R. J. and WINOKUR, G. (1971) Familial differences in schizophrenia with good and poor prognosis. Psychological Med. 1: 326-332.
32. OVERALL, J. E. and GORHAM, D. R. (1962) Brief psychiatric rating scale (BPRS). Psychological Rep. 10: 799-812.
33. REVELEY, A. M. (1994) Phenomenology, environmental risk, and genetics: Twin studies of schizophrenia. In: Schizophrenia: From Mind to Molecule N. C. ANDREASEN (Ed.), pp. 105-118 American Psychiatric Press, Washington, D.C.
34. SAUTTER, F. and GARVER, D. (1985) Familial differences in lithium responsive versus lithium nonresponsive psychoses. J. Psychiatric Res. 19: 1-8.
35. SAUTTER, F. J., MCDERMOTT, B. E. and GARVER, D. L. (1990) A family study of lithium responsive psychosis. J. Affective Disorders. 20: 63-69.
36. SCHEXNAYDER, L. W., HIRSCHOWITZ, J., SAUTTER, F. J. and GARVER, D. L. (1995) Predictors of lithium response in psychoses. Am. J. Psychiat. 152: 1511-1513.
37. SCHULZ, S. C., KAHN, E. M., BAKER, R. W. and CONLEY, R. R. (1990) Lithium and carbamazepine augmentation in treatment-refractory schizophrenia. In: The Neuroleptic-Nonresponsive Patient: Characterization and Treatment B. ANGRIST and S. C. SCHULZ (Eds.), pp. 109-136 American Psychiatric Press, Washington, D.C.
38. SPITZER, R. J. and ENDICOTT, J. (1975) Schedule for Affective Disorders and Schizophrenia - Life-time Version (SADS-L). Biometric Research, New York.
39. SPITZER, R. L., ENDICOTT, J., and ROBINS, E. (1975) Research Diagnostic Criteria. New York, Biometric Research Unit, New York State Department of Mental Hygiene, New York State Psychiatric Institute.
40. WEINBERGER, DR. (1995) Schizophrenia as a neurodevelopmental disorder. In: Schizophrenia S. R. HIRSCH and D. R. WEINBERGER (Eds.), pp. 293-323 Blackwell, Cambridge, MA.
41. YAKELEY, J. and MURRAY, R. M. (1995) Genetic and environmental risk factors for schizophrenia. In: Critical Issues in the Treatment of Schizophrenia N. BRUNELLO, G. RACAGNI, S. Z. LANGER and J. MENDLEWICZ. (Eds.), pp. 9-34 Karger, New York.
42. ZEMLAN, F. P., HIRSCHOWITZ, J., SAUTTER, F. J. and GARVER, D. L. (1984) Impact of lithium therapy on core psychotic symptoms. Br. J. Psychiat. 144: 64-69.